April 6-8, 2020 | Cambridge, MA
Join Avoca for a panel discussion on the latest trends in vendor oversight and contracting, including how to mitigate risk and build in quality-by-design with vendors and partners using effective contracting strategies.
March 25, 2020 – This is an update on how we are addressing the needs of Avoca’s clients and Quality Consortium Members, and the companies that we are working with as part of the Diligent® Qualification Platform, given the extraordinary circumstances that we face with COVID-19. The Avoca Group Operations Avoca and its global team of experts have […]
Read MoreMarch 6, 2020
Washington, DC – The Association of Clinical Research Professionals (ACRP) and The Avoca Group will jointly recognize leading Sponsors and CROs at the ACRP Awards & Recognition Ceremony on Friday, May 1, during the ACRP 2020 annual conference in Seattle, Washington.
March 4, 2020 – Contract Pharma – Jay A. Turpen, Senior Consultant, The Avoca Group – Key first steps to vendor risk management. Are your company’s clinical development vendor qualification (VQ) activities a “Check-The-Box” exercise because someone said that regulators expect it? Or are your VQ activities a comprehensive first step in managing the risk […]
Read More24–25 February 2020 | London
Join Avoca's session, "Define the Framework and Critical Elements of an Effective Oversight Plan: ICH E6 (R2) Requirements for Vendor Oversight."
February 18, 2020 | 11:00am – 12:00pm EST
In this webinar, Crissy MacDonald, Executive Director, Client Delivery, The Avoca Group, will discuss the Quality Tolerance Limit requirements of ICH E6 (R2) and the intersect of Section 3 of ICH E8 (R1), where specific focus is given to proactive quality-by-design in clinical trials, including identifying and managing critical-to-quality factors (CTQs).
February 11, 2020 | 1:00-2:00 pm EST
Join Avoca and Oracle Health Sciences to identify what's needed to mitigate risk and ensure regulatory compliance and audit-readiness in clinical trials.